Inventor · disambiguated record
Timothy David Osslund
Also filed as: OSSLUND TIMOTHY D · OSSLUND TIMOTHY DAVID
16 granted patents·3 pending applications·501 citations·filing 1993–2021
94Inventor score
Top patents by PatentIndex Score
19 records- 0196US5581476AComputer-based methods and articles of manufacture for preparing G-CSF analogsAMGEN INC·Filed 1993·Granted Dec 3, 1996·145 cites·3 claims
- 0293US6632426B2G-CSF analog compositions and methodsAMGEN INC·Filed 2001·Granted Oct 14, 2003·49 cites·4 claims
- 0393US5790421AComputer apparatus for expressing a three dimensional structure of a G-CSF molecule or analogs thereofAMGEN INC·Filed 1995·Granted Aug 4, 1998·102 cites·1 claims
- 0492US7381804B2G-CSF analog compositions and methodsAMGEN INC·Filed 2001·Granted Jun 3, 2008·35 cites·8 claims
- 0590US7276477B2Crystals of etanercept and methods of making thereofAMGEN INC·Filed 2004·Granted Oct 2, 2007·69 cites·29 claims
- 0690US6261550B1G-CSF hybrid molecules and pharmaceutical compositionsAMGEN INC·Filed 1999·Granted Jul 17, 2001·75 cites·25 claims
- 0783US10611850B2Crystalline antibody formulationsAMGEN INC·Filed 2015·Granted Apr 7, 2020·5 cites·33 claims
- 0882US9352043B2High concentration antibody formulationsOSSLUND TIMOTHY DAVID·Filed 2011·Granted May 31, 2016·8 cites·27 claims
- 0981US10064946B2High concentration antibody formulationsAMGEN INC·Filed 2016·Granted Sep 4, 2018·2 cites·29 claims
- 1075US12178873B2High concentration antibody formulationsAMGEN INC·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 1171US11040102B2High concentration antibody formulationsAMGEN INC·Filed 2018·Granted Jun 22, 2021·0 cites·14 claims
- 1269US9145457B2Sclerostin antibody crystals and formulations thereofCLOGSTON CHRISTI L·Filed 2012·Granted Sep 29, 2015·2 cites·20 claims
- 1358US11773184B2Crystalline antibody formulationsAMGEN INC·Filed 2020·Granted Oct 3, 2023·0 cites·18 claims
- 1456US6743422B1Keratinocyte growth factor-2 productsAMGEN INC·Filed 1997·Granted Jun 1, 2004·9 cites·21 claims
- 1554US2004043924A1Uses of keratinocyte growth factor-2Filed 2003·Application pending·0 cites
- 1653US8058398B2Modified G-CSF polypeptideOSSLUND TIMOTHY D·Filed 2005·Granted Nov 15, 2011·0 cites·4 claims
- 1752US9617333B2Sclerostin antibody crystals and formulations thereofAMGEN INC·Filed 2015·Granted Apr 11, 2017·0 cites·13 claims
- 1851US2021047434A1Methods of treating or preventing cholesterol related disordersAMGEN INC·Filed 2020·Application pending·0 cites
- 1940US2014030270A1Methods of treating or preventing cholesterol related disordersAMGEN INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Timothy David Osslund files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →